SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-055593
Filing Date
2021-04-27
Accepted
2021-04-27 16:06:40
Documents
5
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212505-2_def14a.htm DEF 14A 795478
2 GRAPHIC sg_ronaldhwcooper-bw.jpg GRAPHIC 9696
3 GRAPHIC sg_jasonduncan-bw.jpg GRAPHIC 16775
4 GRAPHIC tm212505d1-proxy_01pagebw.jpg GRAPHIC 427602
5 GRAPHIC tm212505d1-proxy_02pagebw.jpg GRAPHIC 513670
  Complete submission text file 0001104659-21-055593.txt   2129666
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33451 | Film No.: 21858950
SIC: 2834 Pharmaceutical Preparations